tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

SoftMedx Healthcare Discloses Historical CEO Emoluments for 2017 and 2018

Story Highlights
  • SoftMedx Healthcare issued a supplementary announcement detailing past CEO emoluments.
  • The disclosure corrects an omission in prior annual reports, improving transparency for investors.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
SoftMedx Healthcare Discloses Historical CEO Emoluments for 2017 and 2018

Claim 50% Off TipRanks Premium

China Wah Yan Healthcare ( (HK:0648) ) has shared an announcement.

SoftMedx Healthcare Limited has issued a supplementary announcement to its previously published 2017 and 2018 annual reports, disclosing that then-chief executive officer Dr. Chan Leung Kwok received emoluments of HK$2.2 million in 2017 and HK$1.9 million in 2018. The clarification enhances transparency over historical executive remuneration and addresses an omission in earlier filings, underscoring the company’s efforts to align with disclosure expectations for listed firms in Hong Kong.

More about China Wah Yan Healthcare

SoftMedx Healthcare Limited operates in the healthcare sector, though the announcement does not specify its exact product lines or services. The company is listed in Hong Kong and governed by a board comprising one executive director and three independent non-executive directors, reflecting a standard corporate governance structure for a listed healthcare company.

Average Trading Volume: 1,710,657

Technical Sentiment Signal: Sell

Current Market Cap: HK$376.3M

For detailed information about 0648 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1